C17orf59 Activators
The realm of C17orf59 activators largely hinges upon the intricate play of cellular processes surrounding endosomes and lysosomes. Chloroquine, known to modulate lysosomal pH, and Bafilomycin A1, a specific inhibitor of vacuolar-type H+-ATPase, both can create ripple effects in lysosomal functionality, thereby affecting BORCS6-associated processes. Given the association of BORCS6 with these organelles, chemicals such as U18666A, which disrupt intracellular cholesterol transport, can cast indirect shadows on BORCS6 activity.
Endocytosis and vesicular trafficking play a central role in the pathways BORCS6 is associated with. This places agents like Wortmannin, Dynasore, and EIPA, which target various components of endocytic processes, in the spotlight. The influence these compounds wield over endocytosis and vesicular movement creates an environment conducive for BORCS6 activity modulation. Similarly, Genistein and LY294002, by inhibiting specific cellular kinases, mold the endocytic landscape, indirectly guiding BORCS6 processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Modulates lysosomal pH. Changes in lysosomal activity can influence BORCS6-associated processes. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Specific inhibitor of vacuolar-type H+-ATPase. Can impact lysosomal function, indirectly affecting BORCS6. | ||||||
U 18666A | 3039-71-2 | sc-203306 sc-203306A | 10 mg 50 mg | $143.00 $510.00 | 2 | |
Disrupts intracellular cholesterol transport, affecting lysosome and endosome functions, and potentially BORCS6. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3 kinase inhibitor. This affects endocytosis and vesicular trafficking, indirectly impacting BORCS6. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Inhibits dynamin, affecting endocytosis and potentially influencing BORCS6-associated processes. | ||||||
5-(N-Ethyl-N-isopropyl)-Amiloride | 1154-25-2 | sc-202458 | 5 mg | $104.00 | 20 | |
Inhibitor of macropinocytosis, affecting endocytic processes and potentially BORCS6. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Inhibits tyrosine kinases and can modulate cellular endocytosis, indirectly affecting BORCS6. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3 kinase inhibitor, modulates vesicular trafficking and can influence BORCS6. | ||||||
Dansylcadaverine | 10121-91-2 | sc-214851 sc-214851A sc-214851B | 100 mg 250 mg 1 g | $52.00 $89.00 $240.00 | 4 | |
Inhibitor of transglutaminase, influencing endocytosis and vesicle trafficking and potentially BORCS6. | ||||||
Methyl-β-cyclodextrin | 128446-36-6 | sc-215379A sc-215379 sc-215379C sc-215379B | 100 mg 1 g 10 g 5 g | $20.00 $48.00 $160.00 $82.00 | 19 | |
Extracts cholesterol from membranes, impacting endocytosis and vesicle trafficking, potentially affecting BORCS6. | ||||||